# Nafarelin

> Nafarelin is a potent synthetic GnRH agonist formulated as an intranasal spray, distinguishing it from most other GnRH agonists that require injection. It is approved for management of endometriosis and central precocious puberty. As with other GnRH agonists, it produces an initial gonadotropin flare followed by sustained hypoestrogenic suppression with continued use. Treatment courses are typically time-limited due to bone density concerns with prolonged hypoestrogenism.

- URL: https://www.lifeconverted.com/peptides/nafarelin
- Also known as: Synarel
- Primary category: Other & Clinical
- Effectiveness rank: #5 in Other & Clinical
- Evidence level: Well studied
- Route: Nasal (Delivered as a metered intranasal spray; it is not injected.)
- Dose range: 400-800 mcg
- Dose tiers: low 400 mcg; moderate 600 mcg; high 800 mcg
- Half-life: Approximately 3 hours
- Timing: As directed by your clinician
- Cycle: Typically up to 6 months per course for endometriosis on, Per prescriber; extended or repeated courses require bone density monitoring off (Prolonged use is limited by hypoestrogenic effects on bone.)
- Storage: Store at room temperature, upright, protected from excess heat; discard per the labeled in-use expiration after opening.

## Mechanism of action

Nafarelin agonizes pituitary GnRH receptors; sustained daily exposure downregulates receptor sensitivity and reduces LH/FSH output, lowering circulating estrogen (or, in precocious puberty, slowing pubertal hormone progression). The intranasal route achieves systemic exposure despite modest and variable bioavailability compared with injectable agonists.

## Reported benefits

- Reduces endometriosis-associated pelvic pain
- Suppresses premature pubertal development in central precocious puberty
- Non-injectable administration route
- Used as an adjunct in some fertility stimulation protocols

## Reported side effects

- Hot flashes
- Vaginal dryness
- Headache
- Nasal irritation
- Bone mineral density loss with extended courses

## Common protocols

- Endometriosis, standard 6-month intranasal course
- Central precocious puberty management

---

Educational information only, not medical advice. Full disclaimer: https://www.lifeconverted.com/disclaimer